Your browser doesn't support javascript.
loading
[Experience of anticipatory therapy with IL-6 receptor inhibitors and perspectives for its use in the evolution of COVID-19].
Chulanov, V P; Bakirov, B A; Vezikova, N N; Gorodin, V N; Zhuravleva, M V; Zagrebneva, A I; Ivanov, I G; Lomakin, N V; Lukina, G V; Moysova, D L; Mutovina, Z I.
Afiliação
  • Chulanov VP; National Medical Research Center for Phthisiopulmonology and Infectious Diseases.
  • Bakirov BA; Bashkir State Medical University.
  • Vezikova NN; Petrozavodsk State University.
  • Gorodin VN; Kuban State Medical University.
  • Zhuravleva MV; Scientific Centre for Expert Evaluation of Medicinal Products.
  • Zagrebneva AI; City Clinical Hospital No. 52.
  • Ivanov IG; Pirogov Russian National Research Medical University.
  • Lomakin NV; City Hospital of St. George the Great Martyr.
  • Lukina GV; Saint Petersburg State University.
  • Moysova DL; Central Clinical Hospital with a Polyclinic of the Administrative Department of the President of the Russian Federation.
  • Mutovina ZI; Central State Medical Academy of the Administrative Department of the President of the Russian Federation.
Ter Arkh ; 94(8): 1028-1035, 2022 Oct 12.
Article em Ru | MEDLINE | ID: mdl-36286985
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: Ru Revista: Ter Arkh Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: Ru Revista: Ter Arkh Ano de publicação: 2022 Tipo de documento: Article